Astrocytopathy in Baló's disease

Multiple Sclerosis Journal

Volumn 17, Issue 7, 2011, Pages 771-779

  Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

aquaporin 4; astrocytopathy; Bal 's disease; concentric lesions; multiple sclerosis (MS); neuromyelitis optica (NMO)

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AQP4 PROTEIN, HUMAN; AUTACOID; AUTOANTIBODY; HEAT SHOCK PROTEIN;

BLOOD BRAIN BARRIER; CASE REPORT; DEMYELINATION; FILIPINO; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MEDLINE; MYELINATION; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PELIZAEUS MERZBACHER DISEASE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SEROLOGY; ADULT; ANIMAL; APOPTOSIS; ASTROCYTE; FEMALE; GLIA; HYPERTROPHY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MYELIN SHEATH; OLIGODENDROGLIA; PATHOLOGY; SCHILDER DISEASE;

ADULT; ANIMALS; APOPTOSIS; AQUAPORIN 4; ASTROCYTES; AUTOANTIBODIES; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT-SHOCK PROTEINS; HUMANS; HYPERTROPHY; INFLAMMATION MEDIATORS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN SHEATH; NEUROGLIA; NEUROMYELITIS OPTICA; OLIGODENDROGLIA;

EID: 79959503871     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511400475     Document Type: Review

References (60)

1. Marburg O. Die so-genannte 'akute multiple Sklerose' (Encephalomyelitis periaxialis scleroticans). Jahrb Psychiatr. 1906 ; 28: 213-312
2. Baló J. Encephalitis periaxialis concentrica. Arch Neurol Psychiatry. 1928 ; 19: 242-264
3. Matsuoka T, Suzuki SO, Iwaki T, Tabira T, Ordinario AT, Kira JI. Aquaporin-4 astrocytopathy in Balo's disease. Acta Neuropathol. 2010 ; 120: 651-660
4. Kuroiwa Y Handbook of clinical neurology. Demyelinating disease. Koetsier JC, ed. Amsterdam: Elsevier ; 1985: 409-417.
5. Courville CB Handbook of clinical neurology. Multiple sclerosis and other demyelinating diseases. Vinken PJ Bruyn GW, ed. Amsterdam: Elsevier ; 1970: 437-451.
6. Bolay H, Karabudak R, Tacal T, Önol B, Selekler K, Saribas SO. Baló's concentric sclerosis. Report of two patients with magnetic resonance imaging follow-up. J Neuroimaging. 1996 ; 6: 98-103 (Pubitemid 26127342)
7. Moore GR, Berry K, Oger JF, Prout AE, Graeb DA, Nugent RA. Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting clinical course. Mult Scler. 2001 ; 7: 375-382 (Pubitemid 33138348)
8. Karaarslan E, Altintas A, Senol U, et al. Baló's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol. 2001 ; 22: 1362-1367 (Pubitemid 32734812)
9. Anschel DJ. Reply to the paper by Wiendl et al.: diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis. Eur Neurol. 2006 ; 55: 111-112 (Pubitemid 43760328)
10. Lindquist S, Bodammer N, Kaufmann J, et al. Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant. Mult Scler. 2007 ; 13: 471-482 (Pubitemid 46796507)
11. Wang C, Zhang KN, Wu XM, et al. Baló's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese. Mult Scler. 2008 ; 14: 418-424 (Pubitemid 351676439)
12. Iannucci G, Mascalchi M, Salvi F, Filippi M. Vanishing Balò-like lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000 ; 69: 399-400 (Pubitemid 30636248)
13. Adams RD, Kubik CS. The morbid anatomy of the demyelinative diseases. Am J Med. 1952 ; 12: 510-546
14. Makifuchi T. Pathology of concentric sclerosis of Baló's disease. Neurol Med. 2002 ; 56: 498-501
15. Moore GRW, Neumann PE, Suzuki K, Lijtmaer HN, Traugott U, Raine CS. Balo's concentric sclerosis: new observations on lesion development. Ann Neurol. 1985 ; 17: 604-611 (Pubitemid 15055580)
16. Kreft KL, Mellema SJ, Hintzen RQ. Spinal cord involvement in Balo's concentric sclerosis. J Neurol Sci. 2009 ; 279: 114-117
17. Yao DL, Webster Hde F, Hudson LD, et al. Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol. 1994 ; 35: 18-30
18. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000 ; 47: 707-717 (Pubitemid 30390191)
19. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci. 2003 ; 206: 187-191 (Pubitemid 36143726)
20. Stadelmann C, Ludwin S, Tabira T, et al. Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. Brain. 2005 ; 128: 979-987 (Pubitemid 40675454)
21. Kishimoto R, Yabe I, Niino M, et al. Baló's concentric sclerosis-like lesion in the brainstem of a multiple sclerosis patient. J Neurol. 2008 ; 255: 760-761
22. Graber JJ, Kister I, Geyer H, Khaund M, Herbert J. Neuromyelitis optica and concentric rings of Baló in the brainstem. Arch Neurol. 2009 ; 66: 274-275
23. Chen CJ, Chu NS, Lu CS, Sung CY. Serial magnetic resonance imaging in patients with Balò's concentric sclerosis: natural history of lesion development. Ann Neurol. 1999 ; 46: 651-656
24. Kastrup O, Stude P, Limmroth V. Balo's concentric sclerosis. Evolution of active demyelination demonstrated by serial contrast-enhanced MRI. J Neurol. 2002 ; 249: 811-814 (Pubitemid 34754214)
25. Wiendl H, Weissert R, Herrlinger U, Krapf H, Küker W. Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis. Eur Neurol. 2005 ; 53: 42-44 (Pubitemid 40522834)
26. Kavanagh EC, Heran MKS, Fenton DM, Lapointe JS, Nugent RA, Graeb DA. Diffusion-weighted imaging findings in Balo concentric sclerosis. Br J Radiol. 2006 ; 79: e28 - e31
27. Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci. 2001 ; 186 (Suppl 1). S25 - S35
28. Mader I, Herrlinger U, Klose U, Schmidt F, Küker W. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003 ; 45: 717-721 (Pubitemid 37376476)
29. Küker W, Ruff J, Gaertner S, Mehnert F, Mäder I, Nagele T. Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging. Neuroradiology. 2004 ; 46: 421-426 (Pubitemid 39004406)
30. Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke. Lancet Neurol. 2006 ; 5: 755-768 (Pubitemid 44205513)
31. Balasubramanya KS, Kovoor JME, Jayakumar PN, et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology. 2007 ; 49: 177-183 (Pubitemid 46218591)
32. Castriota-Scanderbeg A, Sabatini U, Fasano F, et al. Diffusion of water in large demyelinating lesions: a follow-up study. Neuroradiology. 2002 ; 44: 764-767 (Pubitemid 36067861)
33. Rovira A, Pericot I, Alonso J, Rio J, Grivé E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol. 2002 ; 23: 989-994 (Pubitemid 34663446)
34. Rosso C, Remy P, Creange A, Brugieres P, Cesaro P, Hosseini H. Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol. 2006 ; 27: 1006-1008 (Pubitemid 44897676)
35. Balashov KE, Aung LL, Dhib-Jalbut S, Keller IA. Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema. J Neuroimaging 2009 (accessed 28 January 2011).
36. Pichiecchio A, Tavazzi E, Maccabelli G, et al. What insights have new imaging techniques given into aggressive forms of MS -different forms of MS or different from MS?. Mult Scler. 2009 ; 15: 285-293
37. Przeklasa-Auth M, Ovbiagele B, Yim C, Shewmon DA. Multiple sclerosis with initial stroke-like clinicoradiologic features: case report and literature review. J Child Neurol. 2010 ; 25: 732-737
38. Malhotra HS, Jain KK, Agarwal A, et al. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler. 2009 ; 15: 193-203
39. Chen CJ. Serial proton magnetic resonance spectroscopy in lesions of Balo concentric sclerosis. J Comput Assist Tomogr. 2001 ; 25: 713-718
40. Field EJ, Miller H, Russell DS. Observations on glial inclusion bodies in a case of acute disseminated sclerosis. J Clin Pathol. 1962 ; 15: 278-284
41. Currie S, Roberts AH, Urich H. The nosological position of concentric lacunar leucoencephalopathy. J Neurol Neurosurg Psychiatry. 1970 ; 33: 131-137
42. Itoyama Y, Tateishi J, Kuroiwa Y. Atypical multiple sclerosis with concentric or lamellar demyelinated lesions: two Japanese patients studied post mortem. Ann Neurol. 1985 ; 17: 481-487 (Pubitemid 15019988)
43. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
44. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 ; 202: 473-477 (Pubitemid 41186945)
45. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007 ; 130: 1224-1234 (Pubitemid 47355951)
46. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 ; 130: 1194-1205 (Pubitemid 47355941)
47. Masaki K, Matsuoka T, Suzuki SO, et al. Extensive aquaporin-4 (AQP4) loss in Balo's concentric sclerosis in the absence of anti-AQP4 antibody. (Abstract) Mult Scler 2010 (in press).
48. Kinoshita M, Nakatsuji Y, Kimura T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun. 2009 ; 386: 623-627
49. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009 ; 66: 617-629
50. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009 ; 66: 630-643
51. Frydenlund DS, Bhardwaj A, Otsuka T, et al. Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral artery occlusion in mice. Proc Natl Acad Sci U S A. 2006 ; 103: 13532-13536 (Pubitemid 44380142)
52. Fujita Y, Yamamoto N, Sobue K, et al. Effect of mild hypothermia on the expression of aquaporin family in cultured rat astrocytes under hypoxic condition. Neurosci Res. 2003 ; 47: 437-444 (Pubitemid 37433836)
53. Lee M, Lee SJ, Choi HJ, et al. Regulation of AQP4 protein expression in rat brain astrocytes: role of P2X7 receptor activation. Brain Res. 2008 ; 1195: 1-11
54. Meng S, Qiao M, Lin L, Del Bigio MR, Tomanek B, Tuor UI. Correspondence of AQP4 expression and hypoxic-ischaemic brain oedema monitored by magnetic resonance imaging in the immature and juvenile rat. Eur J Neurosci. 2004 ; 19: 2261-2269 (Pubitemid 38582214)
55. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004 ; 18: 1291-1293 (Pubitemid 39561580)
56. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000 ; 6: 159-163 (Pubitemid 30082359)
57. Li L, Zhang H, Verkman AS. Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice. BMC Neurosci. 2009 ; 10: 94-94
58. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003 ; 421: 744-748 (Pubitemid 36227625)
59. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007 ; 25: 821-852 (Pubitemid 46697925)
60. Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007 ; 13: 1173-1175 (Pubitemid 47530640)